• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

The Toothsayer Is Coming

Quote












NFW sorry. Toothsayer says unless you already have a $3M territory margin compression has doomed you to living in a van by the river eating government cheese. Go find a different sales gig, the glory days of being a dental distribution territory rep are gone.
 








That’s easy, PTC real estate was owned, they sold building, Patterson will rent some of lower levels.
Not a lot of money too, but my bet the whole dental division is probably will be separated.
 
















Toothsayer, can Patterson Dental last another 10 years in it's current form so I can get out in my top earning years before being sold to a real management group that will demand accountability with metrics?
 








Shareholders can only hope that Patterson Companies Inc is sold long before 10 years so perhaps we can still find some value in our old age with our stock holdings. Current management has not been able to sustain any solid growth, languishing in the $25 to $29 range, it's their sweet spot.
 












Top Bottom
Back
Quote